×
For best experience we recommend to activate Javascript in your browser.
Recombinant TSLP (Tezepelumab Biosimilar) antibody
Reactivity: Human
ELISA, FACS, SPR, Func, BLI
Host: Human
Monoclonal
unconjugated
Recombinant Antibody
Product Details anti-TSLP (Tezepelumab Biosimilar) Antibody
(hide)
Target
See all TSLP (Tezepelumab Biosimilar) products
TSLP (Tezepelumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
All hosts for TSLP (Tezepelumab Biosimilar) antibodies
Human
Expression System
CHO Cells
Clonality
All clonalities for TSLP (Tezepelumab Biosimilar) antibodies
Monoclonal
Conjugate
All conjugates for TSLP (Tezepelumab Biosimilar) antibodies
This TSLP (Tezepelumab Biosimilar) antibody is un-conjugated
Application
ELISA, Flow Cytometry (FACS), Surface Plasmon Resonance (SPR), Functional Studies (Func), Bio-Layer Interferometry (BLI)
Purpose
Anti-TSLP Reference Antibody (tezepelumab)
Characteristics
Anti-TSLP Reference Antibody (tezepelumab) is expressed from CHO. The heavy chain type is huIgG2, and the light chain type is hulambda. It has a predicted MW of 145.5 kDa.
Purity
>95 %
Isotype
IgG2
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Lyophilized
Concentration
1 mg/mL
Buffer
25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
Storage
4 °C,-80 °C
Storage Comment
+4°C,-80°C
Target Details for TSLP (Tezepelumab Biosimilar)
(hide)
Target
TSLP (Tezepelumab Biosimilar)
Abstract
TSLP (Tezepelumab Biosimilar) Products
Target Type
Biosimilar
Molecular Weight
145.5 kDa
UniProt
Q969D9
Recently viewed
(hide)